Page last updated: 2024-12-11

ethyl oleate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID5363269
CHEMBL ID2106289
CHEBI ID84940
SCHEMBL ID2797
MeSH IDM0103089

Synonyms (72)

Synonym
ethyl oleate ,
nsc-229428
oleic acid, ethyl ester
nsc229428
111-62-6
ethyl cis-9-octadecenoate
9-octadecenoic acid (z)-, ethyl ester
nsc 229428
ai3-00657
fema no. 2450
9-octadecenoic acid, (z)-, ethyl ester
ethyl oleate (natural)
einecs 203-889-5
9-octadecenoic acid (9z)-, ethyl ester
ethyl 9-octadecenoate, (z)-
D04090
ethyl oleate (nf)
ethyl oleate, 98%
ethyl oleate, technical grade, 70%
ethyl oleate, tested according to ph.eur.
oleic acid ethyl ester
ethyl (z)-octadec-9-enoate
O0143
O0054
dtxcid1027633
NCGC00257457-01
tox21_303521
dtxsid3047633 ,
cas-111-62-6
ethyl (9z)-octadecenoate
ethyl (9z)-octadec-9-enoate
85049-36-1
CHEMBL2106289
chebi:84940 ,
z2z439864y ,
ethyl oleate [nf]
unii-z2z439864y
ethyl oleate [ep impurity]
ethyl oleate [fcc]
ethyl oleate [usp-rs]
ethyl 9-octadecenoate
ethyl oleate [ii]
ethyl oleate [fhfi]
ethyl oleate [mart.]
ethyl oleate [ep monograph]
S5367
SCHEMBL2797
ethyloleate
ethyl z-9-octadecenoate
(z)-9-octadecenoic acid ethyl ester
ethyl (9z)-9-octadecenoate #
AC-33783
AKOS025117011
HMS3650O15
mfcd00009579
ethyl oleate, united states pharmacopeia (usp) reference standard
ethyl oleate, analytical standard
ethyl oleate, nf
ethyl oleate, natural, >=85%
ethyl oleate, vetec(tm) reagent grade, 98%
cis-9-octadecenoic acid ethyl ester
SR-01000946820-1
sr-01000946820
Q6578680
CCG-267586
HY-N7103
CS-W009922
A894703
oleic acid-ethyl ester
ethyl oleate; (z)-octadec-9-enoic acid ethyl ester; oleic acid-ethyl ester
EN300-1724742
Z2315574852

Research Excerpts

Overview

Ethyl oleate is a preferred oil candidate due to its integrated advantages. It has a high solubilizing capability, large microemulsion area and effective lymphatic transport.

ExcerptReferenceRelevance
"Ethyl oleate is a preferred oil candidate due to its integrated advantages of high solubilizing capability, large microemulsion area and effective lymphatic transport."( Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously.
Guo, Q; Hu, H; Li, P; Song, J; Wang, K; Wu, C; Xing, Q; Xu, D; You, X, 2016
)
1.42

Toxicity

ExcerptReferenceRelevance
" Adverse events (AEs) were recorded throughout the 12-week trial."( The safety of the use of ethyl oleate in food is supported by metabolism data in rats and clinical safety data in humans.
Balm, TK; Bharaj, SS; Bookstaff, RC; Kelm, GR; Kulick, RM; Murray, JV; PaiBir, S, 2003
)
0.62

Pharmacokinetics

ExcerptReferenceRelevance
" The importance of using both pharmacokinetic and efficacy end points to distinguish between formulations is discussed."( Effect of formulation on the pharmacokinetics and efficacy of doramectin.
Davison, E; Gibson, SP; Kaye, B; Lewis, D; Smith, DG; Weatherley, AJ; Wicks, SR, 1993
)
0.29
" Elimination half-life was significantly lower in the SEDDM Tac group."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39

Compound-Compound Interactions

ExcerptReferenceRelevance
"The toxicity to human bronchial (16-HBE14o-) epithelium cells of nonionic surfactants, polyoxyethylene-10-oleyl ether (C(18:1)E(10)), polyoxyethylene-10-dodecyl ether (C(12)E(10)), and N,N-dimethyl-dodecylamine-N-oxide (C(12)AO) alone or in combination with a range of pharmaceutically acceptable oils (namely, ethyl esters and triglyceride oils), was determined with the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay."( Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil.
Lansley, AB; Lawrence, MJ; Warisnoicharoen, W, 2003
)
0.32

Bioavailability

ExcerptReferenceRelevance
"A positively charged self-emulsifying oil formulation (SEOF), aimed to enhance oral bioavailability of drugs poorly soluble in water, was recently developed."( Charge-dependent interaction of self-emulsifying oil formulations with Caco-2 cells monolayers: binding, effects on barrier function and cytotoxicity.
Benita, S; Gershanik, T; Haltner, E; Lehr, CM, 2000
)
0.31
" Both test materials were well absorbed with approximately 70-90% of the EO dose absorbed and approximately 90-100% of the TG dose absorbed."( The safety of the use of ethyl oleate in food is supported by metabolism data in rats and clinical safety data in humans.
Balm, TK; Bharaj, SS; Bookstaff, RC; Kelm, GR; Kulick, RM; Murray, JV; PaiBir, S, 2003
)
0.62
"The main objective of the study was to investigate the efficacy of microemulsion (ME) to facilitate bioavailability of puerarin (PUE) after oral and nasal administration."( Formulation optimization and bioavailability after oral and nasal administration in rabbits of puerarin-loaded microemulsion.
Cao, F; Cui, J; Gao, Y; Wang, H; Wang, J; Yu, A; Zhai, G, 2011
)
0.37
" After oral administration of RCDE SEDDS capsules or the commercial tablets to fasted rats, the relative bioavailability of SEDDS capsules for protopine and tetrahydropalmatine was 209."( Design and evaluation of self-emulsifying drug delivery systems of Rhizoma corydalis decumbentis extracts.
An, Y; Guo, T; Ma, H; Shi, G; Wang, Y; Zhao, Q, 2012
)
0.38
" Self-microemulsifying drug delivery system (SMEDDS) is a vital tool in solving low bioavailability of poor absorption drugs."( Enhanced bioavailability of total paeony glycoside by self-microemulsifying drug delivery system.
Chen, LJ; Gao, F; Li, L; Liu, Y, 2012
)
0.38
" A self-microemulsifying drug delivery system (SMEDDS) has been developed to enhance the solubility and oral bioavailability of oleanolic acid."( Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation.
Dou, J; Huang, X; Su, L; Yang, R; Zhai, G, 2013
)
0.39
"trans-Ferulic acid (TFA) has antioxidative, anti-inflammatory, and cardioprotective effects, but its poor solubility in water results in unsatisfactory oral bioavailability when administered conventionally at a standard dosage."( Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
Feng, N; Hu, R; Li, Z; Wang, Z; Yang, G; Zhang, K; Zhang, Y; Zhao, J, 2016
)
1.88
"Drug solubility and lymphatic transport enhancements are two main pathways to improve drug oral bioavailability for microemulsions."( Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously.
Guo, Q; Hu, H; Li, P; Song, J; Wang, K; Wu, C; Xing, Q; Xu, D; You, X, 2016
)
0.7
" Self-nanoemulsifying drug delivery system (SNEDDS) is a novel route to improve oral bioavailability of lipophilic drugs."( In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin.
Heli, H; Moezi, L; Nazari-Vanani, R, 2017
)
0.46
"In this study, a nanoemulsion containing mebudipine [composed of ethyl oleate (oil phase), Tween 80 (T80), Span 80 (S80) (surfactants), polyethylene glycol 400, ethanol (cosurfactants), and deionized water] was prepared with the aim of improving its bioavailability for an effective antihypertensive therapy."( Use of artificial neural networks for analysis of the factors affecting particle size in mebudipine nanoemulsion.
Abbasi, S; Amani, A; Keyhanfar, F; Khani, S, 2019
)
0.75
" However, 5-DTAN is a hydrophobic compound with poor aqueous solubility, which limits its oral bioavailability and efficacy."( Preparation and evaluation of self-microemulsifying delivery system containing 5-demethyltangeretin on inhibiting xenograft tumor growth in mice.
Chou, YC; Ho, CT; Li, S; Pan, MH, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" The oleate dosage served as control."( The effect of a single oral dose of ethyl linoleate on urinary prostaglandin E2 excretion in essential fatty acid-deficient rats.
Hansen, HS; Jensen, B, 1985
)
0.27
" This approach led to the identification of formulations based upon sesame oil and ethyl oleate which gave more prolonged doramectin plasma concentrations with no loss in therapeutic efficacy and improved persistent efficacy following subcutaneous administration to cattle at a dosage of 200 micrograms kg-1."( Effect of formulation on the pharmacokinetics and efficacy of doramectin.
Davison, E; Gibson, SP; Kaye, B; Lewis, D; Smith, DG; Weatherley, AJ; Wicks, SR, 1993
)
0.51
" It is concluded that the current microemulsion system might be applicable to formulate the parenteral dosage form of poorly water-soluble flurbiprofen without chemical modification."( Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process.
Hwang, KJ; Kim, CK; Lee, MK; Park, KM, 1999
)
0.3
" This conclusion is based on (1) a decrease in food consumption was noted within the first week (consistent with palatability preferences), (2) there was not a dose-response with regard to food consumption (mid-dose consumed less than high-dose), (3) the lack of cumulative decreases in food consumption which often are observed with toxicity, and (4) anecdotal experiences in our lab show that rats prefer diets containing high triglyceride fat over high EO-fat."( The safety of ethyl oleate is supported by a 91-day feeding study in rats.
Bookstaff, RC; Henwood, SM; Pesik, PK; Stuard, SB; Ward, SR, 2004
)
0.68
" Thus, it is possible to control the in vitro release of poorly soluble drugs from solid oral dosage forms containing SMES."( Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Wan, J; Xu, H; Yang, X; Yi, T, 2008
)
0.35
" However, there are few dosage forms of TPG in the market because of its low bioavailability."( Enhanced bioavailability of total paeony glycoside by self-microemulsifying drug delivery system.
Chen, LJ; Gao, F; Li, L; Liu, Y, 2012
)
0.38
" The selection of the optimum SMEDDS Tac composition might have advantage as an alternative oral dosage form for Tac."( Pharmacokinetics of a self-microemulsifying drug delivery system of tacrolimus.
Gruber, M; Hirt, SW; Kunz, W; Lehle, K; Schmid, C; Touraud, D; von Suesskind-Schwendi, M, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (2 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
The Seaweed Bath Co Heat Care Conditioner - Lime Papaya -- 12 fl ozThe Seaweed Bath CoBeauty & Personal Carecitric acid, ascorbic acid, astaxanthin, cetearyl alcohol, cetyl alcohol, citric acid, tocopherol, panthenol, ectoin, ethyl linoleate, ethyl oleate, ethylhexylglycerin, tocopherol, vitamin E, glyceryl stearate, glycerin, vitamin B5, sodium phosphate, sodium benzoate, trehalose, xylitol2024-11-29 10:47:42
The Seaweed Bath Co Heat Care Shampoo - Lime Papaya -- 12 fl ozThe Seaweed Bath CoBeauty & Personal Carecitric acid, ascorbic acid, astaxanthin, cetearyl alcohol, cetyl alcohol, citric acid, tocopherol, panthenol, ectoin, ethyl linoleate, ethyl oleate, ethylhexylglycerin, tocopherol, vitamin E, glyceryl stearate, glycerin, vitamin B5, sodium phosphate, sodium benzoate, trehalose, xylitol2024-11-29 10:47:42

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
long-chain fatty acid ethyl esterA fatty acid ethyl ester resulting from the formal condensation of the carboxy group of a long-chain fatty acid with the hydroxy group of ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
progesterone receptorHomo sapiens (human)Potency54.48270.000417.946075.1148AID1346784
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.17380.001024.504861.6448AID743215
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (142)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (10.56)18.7374
1990's26 (18.31)18.2507
2000's45 (31.69)29.6817
2010's48 (33.80)24.3611
2020's8 (5.63)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.54 (24.57)
Research Supply Index5.08 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index75.22 (26.88)
Search Engine Supply Index2.15 (0.95)

This Compound (45.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (2.58%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other151 (97.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]